top
Search terms
Results 1 - 10 of 24 - ordered by :
Pages: 1 2 3
Ehjournal

Without a doubt, we have made substantial progress: we can lower blood pressure, if it is too high,1 we can treat hyperlipidaemia as again outlined in the 2016 ESC Guidelines,2 and indeed for the ...

European Heart Journal, Issue @ A Glance, Thomas F. Lüscher

Date : 07/11/2016
Ehjournal

The Framingham study and numerous cohorts thereafter subsequently confirmed the prognostic value of cholesterol and in particular LDL-cholesterol, and the 4S Trial2 eventually proved the cholesterol ...

European Heart Journal, Issue @ A Glance, Thomas F. Lüscher

Date : 14/10/2016 Item size : 197432 bytes
Ehjournal

Download the Issue @ a Glance podcast Subscribe to the EHJ Podcast The evaluation of patients presenting to the emergency department with suspected acute coronary syndrome remains a clinical ...

European Heart Journal, ISSUE @ A GLANCE, Thomas F. Lüscher

Date : 07/08/2016 Item size : 193888 bytes
Ehjournal

Ever since then, smoking cessation has became a cornerstone of prevention.1,2 Later, blood pressure lowering was shown to reduce stroke, infarction, and premature death.3 A major breakthrough was the ...

European Heart Journal, ISSUE @ A GLANCE, Thomas F. Lüscher

Date : 01/08/2016 Item size : 193158 bytes
Ehjournal

Download the Issue @ a Glance podcast Subscribe to the EHJ Podcast In spite of all the progress made over the last decades, atherosclerotic vascular disease remains the most important cause of ...

European Heart Journal, ISSUE @ A GLANCE, Thomas F. Lüscher

Date : 07/06/2016 Item size : 236362 bytes
Ehjournal

[...]in coronary artery disease, not only lipids matter, but inflammation is about to become a major therapeutic target.4 Inflammation involves cellular and humoral factors.5,6 Thus, knowledge of ...

European Heart Journal, ISSUE @ A GLANCE, Thomas F. Lüscher

Date : 14/03/2016
Ehjournal

Furthermore, pressure on publishing, low acceptance rates in prestigious journals, as well as fierce competition for grants have contributed to an increase in scientific misconduct2 and, therefore, ...

European Heart Journal, ISSUE @ A GLANCE, Thomas F. Lüscher

Date : 01/03/2016
Ehjournal

Furthermore, the EMPA-REG OUTCOME trial using the novel antihyperglycaemic agent, empagliflozin,8 a selective sodiumglucose co- transporter inhibitor, significantly reduced cardiovascular mortality; ...

European Heart Journal, ISSUE @ A GLANCE, Thomas F. Lüscher

Date : 07/02/2016
Ehjournal

The Current Opinion paper entitled Surgical and interventional management of mitral valve regurgitation: a position statement from the European Society of Cardiology Working Groups on Cardiovascular ...

European Heart Journal, ISSUE @ A GLANCE, Thomas F. Lüscher

Date : 07/01/2016
Ehjournal

Of note, visible age-related signs such as male pattern boldness, grey hair, facial wrinkles as well as the presence of arcus corneae alone or in combination with appearance factors such as earlobe ...

European Heart Journal, Review, Giovanni G. Camici, Gianluigi Savarese, Alexander Akhmedov, Thomas F. Lüscher

Date : 21/12/2015 Item size : 709930 bytes